Spots Global Cancer Trial Database for ovarian neoplasms
Every month we try and update this database with for ovarian neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biobehavioral Intervention in Gynecologic Oncology Patients | NCT02454036 | Neoplasms Ovarian Neoplas... Uterine Neoplas... Vulva | BBI interventio... | 21 Years - 80 Years | University of Kentucky | |
| A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer | NCT03602859 | Ovarian Neoplas... Ovarian, Fallop... | Niraparib Dostarlimab (TS... Standard of car... Dostarlimab-Pla... Niraparib-Place... | 18 Years - | Tesaro, Inc. | |
| Phase I Platinum Based Chemotherapy Plus Indomethacin | NCT01719926 | Colorectal Neop... Esophageal Neop... Ovarian Neoplas... | Indomethacin | 18 Years - | UMC Utrecht | |
| Pharmacogenomics of Paclitaxel in Ovarian Cancer | NCT00415207 | Ovarian Neoplas... Fallopian Tube ... | 18 Years - | University of Southern Denmark | ||
| Impact of the COVID-19 Pandemic in Gynecological Oncology | NCT04351139 | Gynecologic Can... Breast Neoplasm... Uterine Neoplas... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... | modification of... | 18 Years - | Hospices Civils de Lyon | |
| EDMONd - Elemental Diet in Bowel Obstruction | NCT03150992 | Ovarian Cancer Ovarian Neoplas... Ovarian Disease Peritoneal Neop... Peritoneal Dise... Metastatic Ovar... Primary Periton... Abdominal Neopl... Bowel Obstructi... | Elemental 028 E... | 18 Years - 90 Years | Royal Surrey County Hospital NHS Foundation Trust | |
| Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) | NCT00635193 | Ovarian Cancer,... | M200 (Volocixim... Liposomal Doxor... M200 (Volocixim... M200 (Volocixim... | 18 Years - | AbbVie | |
| Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer | NCT05185947 | Gynecologic Can... Gynecologic Neo... Peritoneal Carc... Peritoneal Neop... Ovarian Cancer Ovarian Neoplas... Colorectal Canc... Colorectal Neop... Appendiceal Can... Appendiceal Neo... | Paclitaxel Nilotinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC) | NCT01329549 | Ovarian Neoplas... | BIBF 1120 (high... BIBF 1120 (medi... BIBF 1120 (low)... | 20 Years - | Boehringer Ingelheim | |
| A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea | NCT04589039 | Ovarian Neoplas... | 19 Years - | Takeda | ||
| Acupuncture for Women's Health Conditions | NCT00090389 | Ovarian Neoplas... Endometriosis Pelvic Pain Uterine Neoplas... | Chinese Acupunc... | 18 Years - | National Center for Complementary and Integrative Health (NCCIH) | |
| Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers | NCT01523678 | Ovarian Cancer Endometrial Can... Uterine Cervica... | Filgrastim Paclitaxel Carboplatin | 18 Years - | Belgian Gynaecological Oncology Group | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| Study of RO7515629 in Participants With HLA-G Positive Solid Tumors | NCT05769959 | Renal Cell Carc... Non-small Cell ... Pancreatic Aden... Colorectal Canc... Ovarian Neoplas... | RO7515629 tocilizumab | 18 Years - | Hoffmann-La Roche | |
| Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy | NCT00109096 | Ovarian Neoplas... Primary Periton... | Pemetrexed | 18 Years - | Eli Lilly and Company | |
| Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients | NCT02444195 | Uterine Cervica... Uterine Neoplas... Ovarian Neoplas... Urogenital Neop... Fallopian Tube ... | Guided Imagery ... | 18 Years - | University of Michigan | |
| A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | NCT01846611 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | Trabectedin DOXIL Dexamethasone DOXIL | 18 Years - | Janssen Research & Development, LLC | |
| Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients | NCT03737643 | Advanced Ovaria... | Bevacizumab Durvalumab Olaparib Placebo olapari... Durvalumab plac... Carboplatin+Pac... | 18 Years - 130 Years | AstraZeneca | |
| Spectroscopy in Ovarian Cancer | NCT04817449 | Ovarian Cancer Ovarian Neoplas... Ovary Cyst Ovary Disease | 18 Years - | University of Exeter | ||
| DNA Single Nucleotide Polymorphisms as Predictors of Toxicity | NCT02478476 | Ovarian Neoplas... Fallopian Tube ... Peritoneal Neop... | 18 Years - | OvaGene Oncology, Inc. | ||
| A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer | NCT01616303 | Ovarian Neoplas... | Carboplatin Paclitaxel oregovomab | 18 Years - 75 Years | Quest PharmaTech Inc. | |
| Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity | NCT02518256 | Ovarian Epithel... | Lavage of the C... | 18 Years - 85 Years | Medical University of Vienna | |
| A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer | NCT00710762 | Ovarian Neoplas... | BIBF1120 Placebo | 18 Years - | Boehringer Ingelheim | |
| Improved Diagnosis of Ovarian Cancer | NCT05842629 | Ovarian Neoplas... Ovarian Cancer Ovarian Cysts Adnexal Mass Adnexal Lesion Adnexal Carcino... Adnexal Neoplas... | - | University of Aarhus | ||
| AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites | NCT00396591 | Ovarian Neoplas... | Aflibercept (zi... | 18 Years - | Sanofi | |
| Venous Thromboembolic Complications in Ovarian Cancer | NCT02480790 | Venous Thromboe... Ovarian Neoplas... Ovarian Cancer Deep Vein Throm... Lung Embolism | 18 Years - 100 Years | Aalborg University Hospital | ||
| Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations | NCT05904730 | Breast Cancer Ovarian Cancer Breast Neoplasm... Ovarian Neoplas... BRCA Mutation HER2-positive B... HER2-negative B... HER-2 Protein O... | Axitinib | 18 Years - | Lynkcell Europe | |
| Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer | NCT00772863 | Ovarian Neoplas... | docetaxel and c... | 18 Years - 70 Years | Sanofi | |
| A Study of LY4170156 in Participants With Selected Advanced Solid Tumors | NCT06400472 | Ovarian Neoplas... Endometrial Neo... Uterine Cervica... Carcinoma, Non-... Triple Negative... Pancreatic Neop... Colorectal Neop... | LY4170156 | 18 Years - | Eli Lilly and Company | |
| Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer | NCT04971421 | Ovarian Neoplas... | ctDNA - circula... TEP - Tumor Edu... | 18 Years - | The Netherlands Cancer Institute | |
| BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer | NCT01121406 | Ovarian Neoplas... | Paclitaxel Gemcitabine Topotecan Pegylated lipos... BI 6727 | 18 Years - | Boehringer Ingelheim | |
| STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer | NCT02676726 | Endometrial Neo... Ovarian Neoplas... | Extraperitoneal... Transperitoneal... | 18 Years - 85 Years | Hospital Universitari Vall d'Hebron Research Institute | |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | NCT01832116 | Ovarian Neoplas... Ovarian Disease... Adnexal Disease... Pancreatic Neop... Digestive Syste... Digestive Syste... Pancreatic Dise... | 89Zr-MMOT0530A | 18 Years - | University Medical Center Groningen | |
| Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer | NCT00074867 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | CP-547,632 | 18 Years - | Pfizer | |
| Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) | NCT04055038 | Ovarian Cancer Ovarian Neoplas... Serous Adenocar... BRCA1 Mutation BRCA2 Mutation Chemotherapy | Platinum-Based ... Conventional ch... | 18 Years - 70 Years | Blokhin's Russian Cancer Research Center | |
| Retrospective Study of Brachytherapy | NCT05242861 | Brachytherapy Uterine Cervica... Uterine Neoplas... Vulvar Cancer Vaginal Cancer Ovarian Neoplas... Gynecologic Neo... | Brachytherapy | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors | NCT02227654 | Ovarian Neoplas... | Abnormal Ovaria... | 25 Years - | University of Kentucky | |
| Questionnaire Study for Gynecological Cancer Survivors | NCT00391664 | Endometrial Neo... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... Genital Neoplas... | Psychosocial | 20 Years - 75 Years | Walter Reed Army Medical Center | |
| A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer | NCT05451849 | Mesothelioma Mesotheliomas P... Mesothelioma, M... Mesothelioma Pe... Ovarian Cancer Ovarian Serous ... Pancreatic Canc... Pancreatic Aden... Colorectal Canc... Triple Negative... TNBC - Triple-N... Ovarian Adenoca... Pancreatic Neop... Colorectal Neop... Ovarian Neoplas... Cholangiocarcin... Non Small Cell ... | TC-510 Fludarabine Cyclophosphamid... | 18 Years - | TCR2 Therapeutics | |
| Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer | NCT00350948 | Ovarian Neoplas... | Telcyta Liposomal Doxor... | 18 Years - | Telik | |
| Early Detection of Cancers in Low Resource Countries | NCT01178736 | Breast Neoplasm... Uterine Cervica... Ovarian Neoplas... Endometrial Neo... | Breast Cancer S... Cervical Cancer... Ovarian Cancer ... Endometrial Can... | 30 Years - 64 Years | Woman's Cancer Foundation | |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | NCT01950572 | Mesothelioma Thymoma Pancreatic Neop... Biliary Tract N... Stomach Neoplas... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer | NCT00246688 | Ovarian Neoplas... | Sagopilone (BAY... | 18 Years - | Bayer | |
| Developing a Test for the Detection of Ovarian Cancer | NCT04794322 | Ovarian Neoplas... Ovarian Epithel... Fallopian Tube ... High Grade Ovar... Stage I Ovarian... Stage II Ovaria... Stage III Ovari... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IVA Ovari... Stage IVB Ovari... | Uterine lavage,... Blood sample Pap smear | 30 Years - | Massachusetts General Hospital | |
| ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer | NCT00325351 | Ovarian Neoplas... | Sagopilone (ZK ... | 18 Years - | Bayer | |
| Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer | NCT00046800 | Ovarian Neoplas... | OSI-211 (Liposo... | 18 Years - | Astellas Pharma Inc | |
| Biobehavioral-Cytokine Interactions in Ovarian Cancer | NCT01113112 | Ovarian Neoplas... | 18 Years - | University of Iowa | ||
| Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes. | NCT02062697 | Ovarian Epithel... | Lavage of the C... Liquid-PAP smea... | 18 Years - 80 Years | Medical University of Vienna | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer | NCT01932125 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | Bevacizumab | 18 Years - | Hoffmann-La Roche | |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | NCT01950572 | Mesothelioma Thymoma Pancreatic Neop... Biliary Tract N... Stomach Neoplas... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors | NCT02499952 | Germ Cell Neopl... Testicular Neop... Non Seminomatou... Mediastinal Neo... Genital Neoplas... Genital Neoplas... Ovarian Neoplas... | Pembrolizumab | 18 Years - | Hoosier Cancer Research Network | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Improved Diagnosis of Ovarian Cancer | NCT05842629 | Ovarian Neoplas... Ovarian Cancer Ovarian Cysts Adnexal Mass Adnexal Lesion Adnexal Carcino... Adnexal Neoplas... | - | University of Aarhus | ||
| A Study of SGN-B7H4V in Advanced Solid Tumors | NCT05194072 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... Triple Negative... HER2 Negative B... Hormone Recepto... Endometrial Neo... Carcinoma, Non-... Cholangiocarcin... Gallbladder Car... Adenoid Cystic ... | SGN-B7H4V | 18 Years - | Seagen Inc. | |
| Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma | NCT00226915 | Epithelial Ovar... Primary Periton... Fallopian Tube ... | Paclitaxel+Carb... Paclitaxel+Carb... | 20 Years - | Japanese Gynecologic Oncology Group | |
| An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy | NCT00191646 | Genital Neoplas... Fallopian Tube ... Ovarian Neoplas... Pelvic Neoplasm... Peritoneal Neop... | Gemcitabine Paclitaxel Carboplatin | 18 Years - | Eli Lilly and Company | |
| A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 | NCT06003231 | Carcinoma, Squa... Carcinoma, Non-... Ovarian Neoplas... Endometrial Neo... | disitamab vedot... | 18 Years - | Seagen Inc. | |
| Spectroscopy in Ovarian Cancer | NCT04817449 | Ovarian Cancer Ovarian Neoplas... Ovary Cyst Ovary Disease | 18 Years - | University of Exeter | ||
| Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms | NCT00160472 | Ovarian Neoplas... | removal of ovar... | 18 Years - | Tripler Army Medical Center | |
| Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer | NCT00069160 | Lung Neoplasms Ovarian Neoplas... Cervix Neoplasm... Renal Neoplasms | docetaxel tariquidar 99mTc-sestamibi... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib | NCT04676334 | Metastatic Cast... Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... Other Solid Tum... | Rucaparib | 18 Years - | pharmaand GmbH | |
| Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy | NCT00109096 | Ovarian Neoplas... Primary Periton... | Pemetrexed | 18 Years - | Eli Lilly and Company | |
| Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer | NCT03858166 | Adjuvant Chemot... Ovarian Neoplas... Ovarian Cancer | PEG-rhG-CSF | 18 Years - 80 Years | Shandong University | |
| OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 | NCT00112086 | Ovarian Neoplas... Fallopian Tube ... Peritoneal Neop... | Neoadjuvant che... | 20 Years - 75 Years | Japan Clinical Oncology Group | |
| Risk of Ovarian Cancer in Patients With a Pelvic Mass | NCT00315692 | Ovarian Cancer | Biomarker Assay... | 18 Years - | Fujirebio Diagnostics, Inc. | |
| Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib | NCT03314740 | Ovarian Neoplas... | Paclitaxel Cediranib Olaparib | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer | NCT00035100 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | epothilone b | 18 Years - | Novartis | |
| Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer | NCT01313078 | Ovarian Neoplas... Fallopian Tube ... Primary Periton... | Pegylated L-Asp... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients | NCT01523652 | Genital Disease... Ovarian Neoplas... Urogenital Neop... | 18 Years - | Azienda Ospedaliera San Giovanni Battista | ||
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | NCT02632448 | Solid Tumors Colorectal Canc... Breast Cancer Ovarian Cancer Colon Cancer Rectal Cancer Neoplasms Endometrial Can... Soft Tissue Sar... Triple Negative... Pancreas Cancer Pancreatic Canc... | LY2880070 Gemcitabine | 18 Years - | Esperas Pharma Inc. | |
| Risk of Ovarian Cancer in Patients With a Pelvic Mass | NCT00315692 | Ovarian Cancer | Biomarker Assay... | 18 Years - | Fujirebio Diagnostics, Inc. | |
| Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery | NCT05300711 | Salpingectomy Colorectal Surg... | Bilateral salpi... Colorectal surg... | 15 Years - 80 Years | University of British Columbia | |
| Venous Thromboembolic Complications in Ovarian Cancer | NCT02480790 | Venous Thromboe... Ovarian Neoplas... Ovarian Cancer Deep Vein Throm... Lung Embolism | 18 Years - 100 Years | Aalborg University Hospital | ||
| Blood Collection From People With Ovarian Cancer | NCT02063464 | Ovarian Cancer Cancer of the O... Ovarian Neoplas... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020) | NCT00746694 | Ovarian Neoplas... Breast Neoplasm... Paresthesia | 18 Years - | Merck Sharp & Dohme LLC | ||
| TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer | NCT00052065 | Ovarian Neoplas... | TLK286 | 18 Years - | Telik | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors | NCT00841191 | Ovarian Neoplas... Pancreatic Neop... Colorectal Neop... Head and Neck N... Lung Neoplasms | CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... CNTO 328; Anti-... | 18 Years - | Centocor, Inc. | |
| Acupuncture for Women's Health Conditions | NCT00090389 | Ovarian Neoplas... Endometriosis Pelvic Pain Uterine Neoplas... | Chinese Acupunc... | 18 Years - | National Center for Complementary and Integrative Health (NCCIH) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
